Latest Biotech News

A suite of innovative spatial biology tools is revolutionizing how researchers visualize and analyze complex molecular landscapes within tissues. The Giotto Suite software facilitates integration...

Recent studies demonstrate major advances in diagnostics aided by AI and molecular markers. Predicta Biosciences secured $23.4 million in Series A funding to expand its blood cancer and autoimmune...

Recent clinical advancements underscore growing momentum in cancer therapeutics. Research highlights the potential of radioligand therapy in metastatic prostate cancer, demonstrating novel...

Innovative gene therapy and molecular research offer promising advancements across several disease domains. Paris-based biotech announced encouraging initial results from a gene therapy targeting...

Researchers have unveiled key advances improving battery technologies and sustainable energy systems. Studies include development of engineered membranes for selective lithium extraction from...

The US government shutdown commencing October 1, 2025, poses significant challenges for the scientific community. Key science agencies, including the NIH and NSF, have halted non-essential...

Amgen announced a landmark clinical trial demonstrating that its PCSK9 inhibitor, Repatha, significantly reduces the incidence of heart disease events in patients without prior cardiovascular...

Japanese pharmaceutical giant Takeda announced it will discontinue all cell therapy research, a field once central to its genetic medicine strategy. This marks Takeda's full retreat from cell...

Pharmaceutical companies including AbbVie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex have formed a consortium to share proprietary structural data, boosting AI-powered drug...

Biotech firms continue to push the boundaries in gene editing and bispecific antibody engineering. UK-based Forge Genetics secured £2 million to develop a novel gene editing platform as an...

Recent studies have unveiled novel insights into neurodegenerative diseases. Researchers at the La Jolla Institute and Columbia University provided strong evidence that amyotrophic lateral...

Cutting-edge biotechnologies are emerging in gene therapy and protein manufacturing. Cirrus Therapeutics launched with $11 million to develop gene therapies targeting eye aging diseases by...

Research progresses in novel cancer treatments and biomarker discovery. Genialis partnered with Cleveland Clinic to develop AI-assisted predictive biomarkers for pancreatic cancer therapy...

Significant strides are being made in lung cancer care. A dynamic nomogram model was developed to predict brain metastasis risk in stage III non-small cell lung cancer patients undergoing...

The ongoing U.S. federal government shutdown has significantly impacted the FDA’s regulatory functions, particularly halting acceptance of new drug and biologic submissions that require user fees....

Pfizer has become the first pharmaceutical company to agree to the Trump administration's most-favored nation (MFN) drug pricing plan, aligning US drug prices with those in comparable developed...

Japanese pharmaceutical giant Takeda announced complete discontinuation of its cell therapy research efforts after previously scaling back its work in this space. The company plans to seek...

Danish biotechnology company Genmab is set to acquire clinical-stage biotech Merus in an $8 billion all-cash deal focused on accelerating growth through Merus' lead asset, petosemtamab, an...

Multiple AI-driven innovations are transforming cancer diagnostics and drug development. Notably, a collaboration involving pharmaceutical giants Abbvie, J&J, Bristol Myers Squibb, Takeda, and...

Cutting-edge spatial omics and proteomic platforms are advancing biomarker discovery and disease characterization. The GeoMx Discovery Proteome Atlas offers high-plex protein profiling with over...